Therorna completes Series A Financing to Accelerate Pipeline Development and Clinical Transformation of circRNA-based platform
Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new vaccines and therapies, announced the completion of a US$42